Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Active not recruiting 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Prostatic Neoplasms 12Glioblastoma 11Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 8Oropharyngeal Neoplasms 7Lung Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Burkitt Lymphoma 5Astrocytoma 5Urinary Bladder Neoplasms 4Carcinoma 4Adenocarcinoma of Lung 4Sarcoma 3Rhabdomyosarcoma, Embryonal 3Rhabdomyosarcoma 3Rectal Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Nasopharyngeal Carcinoma 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hodgkin Disease 3Gliosarcoma 3Glioma 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Rhabdomyosarcoma, Alveolar 2Prostate Adenocarcinoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Cyclophosphamide 10Nivolumab 7pembrolizumab 6fludarabine phosphate 6fludarabine 5Mycophenolic Acid 5Specimen Handling 4Magnetic Resonance Spectroscopy 4Doxorubicin 4Dacarbazine 4Cyclosporine 4Brentuximab Vedotin 4Whole-Body Irradiation 3Vinblastine 3Radiotherapy 3Filgrastim 3Etoposide 3Busulfan 3Tacrolimus 2Sirolimus 2Radiation 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Clofarabine 2Carmustine 2tocilizumab 1thymoglobulin 1tafasitamab 1polatuzumab vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hodgkin Disease × Radiotherapy × 30 days × Clear all
NCT00846742 2026-05-26

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
88 enrolled 21 charts
Lymphoid

Hodgkin Disease

NCT01920932 2026-05-06

Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
77 enrolled 20 charts
Lymphoid

Hodgkin Disease, Neoplasms

NCT03907488 2026-05-04

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
994 enrolled 11 charts 1 FDA
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡